NCT04065399 2026-03-18
AUGMENT-101
Syndax Pharmaceuticals
Phase 1/2 Recruiting
Clinical Trials
4 trialsNCT05918913 2025-09-05
Expanded Access Program for Revumenib
Syndax Pharmaceuticals
No longer available
NCT05406817 2025-01-10
Study of Radiolabeled Revumenib in Adults With Acute Leukemia
Syndax Pharmaceuticals
Phase 1 Completed
NCT05326516 2024-08-13
A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia
Syndax Pharmaceuticals
Phase 1 Completed